Combating an increasingly global pandemic with relevant, translatable models.

Obesity is a major public health issue affecting not only developed, but also developing countries worldwide. Patients suffering from obesity are at a significantly increased risk of developing a plethora of medical problems, including hypertension, cardiovascular disease, sleep apnea, hyperuricemia, dyslipidemia, stroke, gallbladder disease, osteoarthritis, gout, insulin resistance and type 2 diabetes mellitus. Obesity is also associated with certain types of cancer, notably breast, endometrial and gallbladder cancer in women, and prostate and colorectal cancer in men.

With the incidence of obesity on the rise, the need for improved treatments is more relevant than ever. At PharmaLegacy, we are dedicated to providing your obesity and hyperlipemia pipelines with the animal models you need to properly assess any potential therapies.

When there’s a lot on the line, let PharmaLegacy get the correct answers.

Contact Us
Obesity and Hyperlipidemia


Ensuring superior quality:

  • Research data electronically managed by BioBook (IDBS, UK)
  • AAALAC accredited vivarium
  • 380,000 square feet of facility space
  • 1000+ validated animal models of disease spanning 40+ diseases

Our team of experts at PharmaLegacy is devoted to quality. Get in touch with them now, and let’s get your pipeline going.

Contact Us

We’re ready when you are.

Tell us your pharmacology challenges.